MX2020011873A - Nuevos derivados de quinolina. - Google Patents

Nuevos derivados de quinolina.

Info

Publication number
MX2020011873A
MX2020011873A MX2020011873A MX2020011873A MX2020011873A MX 2020011873 A MX2020011873 A MX 2020011873A MX 2020011873 A MX2020011873 A MX 2020011873A MX 2020011873 A MX2020011873 A MX 2020011873A MX 2020011873 A MX2020011873 A MX 2020011873A
Authority
MX
Mexico
Prior art keywords
sup
compounds
new quinoline
quinoline derivatives
preparing
Prior art date
Application number
MX2020011873A
Other languages
English (en)
Inventor
Johannes Köbberling
Walter Hübsch
Niels Lindner
Claudia Welz
Adeline Köhler
Kirsten Börngen
Daniel Kulke
Nils Griebenow
Bernd Alig
Ulrich Görgens
Thomas Ilg
Claudia Böhm
Maike Hink
Iring Heisler
Hans- Georg Schwarz
Wei Zhuang
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of MX2020011873A publication Critical patent/MX2020011873A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La invención abarca nuevos compuestos de quinolina de la fórmula general (I): (ver Fórmula), en la cual A, R1, R2, R3, R4, R5, R6 y Q son como se definen en el presente, procedimientos para la elaboración de dichos compuestos, compuestos intermedios útiles para la elaboración de dichos compuestos, composiciones farmacéuticas y combinaciones que comprenden dichos compuestos y el uso de dichos compuestos para la elaboración de composiciones farmacéuticas para el tratamiento, control y/o prevención de enfermedades, en particular de infecciones con helmintos, como un único agente o en combinación con otros principios activos.
MX2020011873A 2018-05-09 2019-05-07 Nuevos derivados de quinolina. MX2020011873A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18171490 2018-05-09
PCT/EP2019/061725 WO2019215182A1 (en) 2018-05-09 2019-05-07 New quinoline derivatives

Publications (1)

Publication Number Publication Date
MX2020011873A true MX2020011873A (es) 2021-01-20

Family

ID=62148180

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011873A MX2020011873A (es) 2018-05-09 2019-05-07 Nuevos derivados de quinolina.

Country Status (21)

Country Link
US (2) US11572357B2 (es)
EP (1) EP3790874B1 (es)
JP (1) JP7403472B2 (es)
KR (1) KR20210006401A (es)
CN (1) CN112074514A (es)
AU (1) AU2019266511B2 (es)
BR (1) BR112020022619A2 (es)
CA (1) CA3099610A1 (es)
CL (1) CL2020002891A1 (es)
CO (1) CO2020013876A2 (es)
DK (1) DK3790874T3 (es)
ES (1) ES2945559T3 (es)
IL (1) IL278472B2 (es)
MX (1) MX2020011873A (es)
PH (1) PH12020551891A1 (es)
PL (1) PL3790874T3 (es)
PT (1) PT3790874T (es)
SG (1) SG11202010024UA (es)
TW (1) TWI813680B (es)
UY (1) UY38226A (es)
WO (1) WO2019215182A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7324846B2 (ja) * 2018-12-18 2023-08-10 エランコ・ティアゲゾンタイト・アーゲー 二環式誘導体
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022020315A2 (pt) 2020-04-09 2022-12-13 Bayer Animal Health Gmbh Novos compostos anti-helmínticos
MX2022015038A (es) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos.
CN116600807A (zh) 2020-12-11 2023-08-15 英特维特国际股份有限公司 包含噻吩并吡啶结构的驱虫化合物
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
AR127495A1 (es) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelmínticos

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
EP0263209A2 (en) * 1986-10-08 1988-04-13 The Upjohn Company Anthelmintic quinolinyl acylhydrazones
WO1986005982A2 (en) * 1985-04-11 1986-10-23 Upjohn Co Anthelmintic quinolinyl acylhydrazones, method of use and compositions
JPS62502469A (ja) * 1985-04-11 1987-09-24 ジ・アップジョン・カンパニ− 駆虫薬キノリニル・アシルヒドラゾン、その使用方法およびその組成物
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
DE4123918A1 (de) * 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
EP2264030A1 (en) 2003-10-17 2010-12-22 Incyte Corporation Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
RU2394819C2 (ru) 2004-10-20 2010-07-20 Кумиай Кемикал Индастри Ко., Лтд. Инсектицид, акарицид и нематоцид, содержащие в качестве активного компонента производное 3-триазолилфенилсульфида
BRPI0616667B1 (pt) 2005-10-06 2017-07-18 Nippon Soda Co. , Ltd. Compounds of cyclical amine or salts thereof or non-oxides thereof, and agents for control of fever
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び／または予防剤
JP5268461B2 (ja) 2008-07-14 2013-08-21 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
DK2369934T3 (da) 2008-12-12 2014-06-16 Syngenta Participations Ag Spiroheterocykliske n-oxypiperidiner som pesticider
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
KR20130080485A (ko) 2010-05-31 2013-07-12 신젠타 파티서페이션즈 아게 작물 강화 방법
EP2959775A1 (en) 2010-08-31 2015-12-30 Meiji Seika Pharma Co., Ltd. Pest control agent
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
EP2675440B1 (en) 2011-02-14 2020-03-25 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
KR20140088194A (ko) 2011-11-04 2014-07-09 에프. 호프만-라 로슈 아게 아릴-퀴놀린 유도체
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
AR089939A1 (es) 2012-02-09 2014-10-01 Glenmark Pharmaceuticals Sa COMPUESTOS BICICLICOS COMO INHIBIDORES DE mPGES-1
MX2014011829A (es) 2012-03-30 2015-03-19 Basf Se Compuestos de piridinilideno n-sustituidos y derivados para combatir plagas de animales.
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
NZ700590A (en) 2012-04-27 2016-03-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP6267193B2 (ja) 2012-05-22 2018-01-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 置換ジピリジルアミン類及びそれらの使用
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
US20160081342A1 (en) 2013-05-23 2016-03-24 Syngenta Participations Ag Tank-mix formulations
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
WO2015058021A1 (en) 2013-10-17 2015-04-23 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
CN105636441B (zh) 2013-10-17 2018-06-15 美国陶氏益农公司 制备杀虫化合物的方法
AR098475A1 (es) 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
KR101961581B1 (ko) 2015-02-17 2019-03-22 닛뽕소다 가부시키가이샤 농약 조성물
AU2016370779B2 (en) 2015-12-17 2019-07-25 Astex Therapeutics Limited Quinoline-3-carboxamides as H-PGDS inhibitors
JP7165129B2 (ja) 2016-11-11 2022-11-02 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規な駆虫性キノリン－３－カルボキサミド誘導体

Also Published As

Publication number Publication date
BR112020022619A2 (pt) 2021-02-02
IL278472B2 (en) 2023-08-01
WO2019215182A1 (en) 2019-11-14
EP3790874A1 (en) 2021-03-17
IL278472B1 (en) 2023-04-01
DK3790874T3 (da) 2023-05-15
JP7403472B2 (ja) 2023-12-22
CA3099610A1 (en) 2019-11-14
EP3790874B1 (en) 2023-03-15
CO2020013876A2 (es) 2020-11-20
AU2019266511A1 (en) 2020-10-22
US20210139468A1 (en) 2021-05-13
PT3790874T (pt) 2023-05-31
KR20210006401A (ko) 2021-01-18
CL2020002891A1 (es) 2021-05-14
AU2019266511B2 (en) 2022-12-08
US20230141809A1 (en) 2023-05-11
TW202016100A (zh) 2020-05-01
PL3790874T3 (pl) 2023-06-19
IL278472A (es) 2020-12-31
TWI813680B (zh) 2023-09-01
PH12020551891A1 (en) 2021-05-31
ES2945559T3 (es) 2023-07-04
SG11202010024UA (en) 2020-11-27
CN112074514A (zh) 2020-12-11
US11572357B2 (en) 2023-02-07
UY38226A (es) 2019-12-31
JP2021523131A (ja) 2021-09-02

Similar Documents

Publication Publication Date Title
MX2020001403A (es) Nuevos derivados de quinolina.
PH12019501034A1 (en) New anthelmintic quinoline-3-carboxamide derivatives
PH12018550173A1 (en) Pyrazolopyrimidine derivatives
PH12019500932A1 (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
PH12019502851A1 (en) New azaquinoline derivatives
MX2020011873A (es) Nuevos derivados de quinolina.
MX2021004707A (es) Nuevos compuestos antihelminticos.
WO2020097537A3 (en) Fused ring compounds
PH12018502472A1 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
PH12019501846A1 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
WO2018077944A3 (en) 4,5-annulated 1,2,4-triazolones
MX2019012803A (es) Nuevos derivados de pirazol biciclicos.
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
MX2020001404A (es) Dihidrooxadiazinonas.
WO2020126968A3 (en) Urea derivatives for use against proliferative diseases
WO2017198341A8 (en) MACROCYCLIC INDOLE DERIVATIVES
MX2020004981A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3.
AU2019322713A8 (en) Novel medicament for treating inflammatory bowel disease
PH12019502652A1 (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases